Table: Phoenixbio -2023/24 group results

PhoenixBio

15/05/2024 07:30

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to        NEXT    
                Mar 31, 2024    Mar 31, 2023   Mar 31, 2025      YEAR      
                   LATEST         YEAR-AGO        COMPANY       COMPANY    
                   RESULTS         RESULTS       FORECAST     H1 FORECAST  
  Sales             1.72            2.12           2.12         972 mln    
                 (-19.2 pct)     (+60.3 pct)    (+23.7 pct)   (+10.3 pct)  
  Operating        11 mln          508 mln        214 mln      loss 5 mln  
                 (-97.8 pct)                                               
  Recurring        43 mln          511 mln        214 mln      loss 5 mln  
                 (-91.5 pct)                   (+393.6 pct)                
  Net
  Net              26 mln          493 mln        201 mln      loss 8 mln  
                 (-94.7 pct)                   (+662.3 pct)                
  EPS             6.98 yen       145.23 yen      49.92 yen   loss 2.23 yen 
  EPS Diluted                     97.29 yen                                
  Ann Div            NIL             NIL            NIL                    
  -Q2 Div            NIL             NIL            NIL                    
  -Q4 Div            NIL             NIL            NIL                    
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T